Web Analytics

Dealing with Inventions Combining Software and Biotech

AUTM Annual Meeting 2023
 | 1:45 - 3 p.m. Central

JW Marriott Austin
110 E 2nd St, Austin, TX 78701

Some invention disclosures are difficult to categorize as either a biotech or software. Yet, inventions still need to be assigned to license managers, patent attorneys and patent examiners who won’t necessarily have technical expertise covering everything from artificial intelligence to antibody design. Often, a team approach is necessary to truly determine what is novel about an invention, and whether that novelty lies in a computer or biology field. Stephanie Vavra and the panel will discuss how they determine whether a disclosure is worthy of a patent application, how the staff work on the patent application and how it gets assigned to a patent examiner.

Follow Quarles

Subscribe Media Contact
Back to Main Content

We use cookies to provide you with the best user experience on our website and to analyze statistics related to our website. To understand more about how we use cookies, or for instructions to change your preference and browser settings, please see our Privacy Notice. Please note that if you choose to reject cookies, doing so may impair some of our website's functionality.